|
Name |
Kampanol A
|
| Molecular Formula | C25H32O6 | |
| IUPAC Name* |
[(1S,13R,14S,17S,19R)-10-hydroxy-1,14,18,18-tetramethyl-7-oxo-2,6-dioxapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-3,8,10-trien-17-yl] acetate
|
|
| SMILES |
CC(=O)O[C@H]1CC[C@]2([C@H](C1(C)C)CC[C@]3([C@@H]2CC4=C(C=C5C(=C4O3)COC5=O)O)C)C
|
|
| InChI |
InChI=1S/C25H32O6/c1-13(26)30-20-7-8-24(4)18(23(20,2)3)6-9-25(5)19(24)11-15-17(27)10-14-16(21(15)31-25)12-29-22(14)28/h10,18-20,27H,6-9,11-12H2,1-5H3/t18-,19+,20-,24-,25-/m0/s1
|
|
| InChIKey |
BOVRDZLKBBUXQQ-BOWIAGTOSA-N
|
|
| Synonyms |
Kampanol A; CHEMBL62448; CHEBI:67848; BDBM50071241; Q27136325; (6aR)-9alpha-Acetoxy-5-hydroxy-6,6abeta,6b,7,8,9,10,10abeta,11,12-decahydro-6balpha,10,10,12abeta-tetramethyl-12aH-2,13-dioxa-2H-benzo[a]cyclopenta[h]anthracene-3(1H)-one; [(1S,13R,14S,17S,19R)-10-hydroxy-1,14,18,18-tetramethyl-7-oxo-2,6-dioxapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-3,8,10-trien-17-yl] acetate; Acetic acid (6aR,6bS,9S,10aR,12aS)-5-hydroxy-6b,10,10,12a-tetramethyl-3-oxo-3,6,6a,6b,7,8,9,10,10a,11,12,12a-dodecahydro-1H-2,13-dioxa-benzo[a]cyclopenta[h]anthracen-9-yl ester
|
|
| CAS | NA | |
| PubChem CID | 10094096 | |
| ChEMBL ID | CHEMBL62448 |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 428.5 | ALogp: | 4.5 |
| HBD: | 1 | HBA: | 6 |
| Rotatable Bonds: | 2 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 82.1 | Aromatic Rings: | 5 |
| Heavy Atoms: | 31 | QED Weighted: | 0.632 |
| Caco-2 Permeability: | -4.934 | MDCK Permeability: | 0.00001850 |
| Pgp-inhibitor: | 0.212 | Pgp-substrate: | 0.009 |
| Human Intestinal Absorption (HIA): | 0.007 | 20% Bioavailability (F20%): | 0.005 |
| 30% Bioavailability (F30%): | 0.033 |
| Blood-Brain-Barrier Penetration (BBB): | 0.062 | Plasma Protein Binding (PPB): | 94.46% |
| Volume Distribution (VD): | 1.147 | Fu: | 10.48% |
| CYP1A2-inhibitor: | 0.118 | CYP1A2-substrate: | 0.178 |
| CYP2C19-inhibitor: | 0.018 | CYP2C19-substrate: | 0.292 |
| CYP2C9-inhibitor: | 0.242 | CYP2C9-substrate: | 0.583 |
| CYP2D6-inhibitor: | 0.237 | CYP2D6-substrate: | 0.271 |
| CYP3A4-inhibitor: | 0.166 | CYP3A4-substrate: | 0.316 |
| Clearance (CL): | 11.101 | Half-life (T1/2): | 0.245 |
| hERG Blockers: | 0.033 | Human Hepatotoxicity (H-HT): | 0.246 |
| Drug-inuced Liver Injury (DILI): | 0.044 | AMES Toxicity: | 0.009 |
| Rat Oral Acute Toxicity: | 0.683 | Maximum Recommended Daily Dose: | 0.858 |
| Skin Sensitization: | 0.329 | Carcinogencity: | 0.154 |
| Eye Corrosion: | 0.003 | Eye Irritation: | 0.304 |
| Respiratory Toxicity: | 0.968 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC002748 | ![]() |
0.780 | D04GJN | ![]() |
0.275 | ||
| ENC002749 | ![]() |
0.705 | D0I2SD | ![]() |
0.264 | ||
| ENC005020 | ![]() |
0.566 | D07BSQ | ![]() |
0.263 | ||
| ENC002750 | ![]() |
0.519 | D0F1UL | ![]() |
0.263 | ||
| ENC002192 | ![]() |
0.500 | D0X4RS | ![]() |
0.262 | ||
| ENC002044 | ![]() |
0.457 | D02CJX | ![]() |
0.260 | ||
| ENC003259 | ![]() |
0.445 | D0U3GL | ![]() |
0.259 | ||
| ENC005397 | ![]() |
0.417 | D0EP0C | ![]() |
0.258 | ||
| ENC001949 | ![]() |
0.415 | D09NNA | ![]() |
0.256 | ||
| ENC002386 | ![]() |
0.409 | D02CNR | ![]() |
0.256 | ||